Only first intravitreal bevacizumab injection achieves statistically significant visual improvement in naïve myopic choroidal neovascularization

References

• VirgiliGMenchiniFLaser photocoagulation for choroidal neovascularisation in pathologic myopiaCochrane Database Syst Rev200519CD00476516235380
   PubMedGoogle Scholar
• BlinderKJBlumenkranzMSBresslerNMVerteporfin therapy of subfoveal CNV in pathologic myopia: 2-year results of a randomized clinical trial – VIP report no. 3Ophthalmology200311066767312689884
   PubMed Web of Science ®Google Scholar
• SilvaRMRuiz-MorenoJMRosaPIntravitreal ranibizumab for myopic choroidal neovascularization: 12-month resultsRetina20103040741220094007
   PubMed Web of Science ®Google Scholar
• SilvaRMRuiz-MorenoJMNascimentoJShort-term efficacy and safety of intravitreal ranibizumab for myopic choroidal neovascularizationRetina2008281117112318788102
   PubMed Web of Science ®Google Scholar
• LaiTYChanWMLiuDTLamDSIntravitreal ranibizumab for the primary treatment of choroidal neovascularization secondary to pathologic myopiaRetina20092975075619357555
   PubMed Web of Science ®Google Scholar
• KonstantinidisLMantelIPournarasJAZografosLAmbresinAIntravitreal ranibizumab (Lucentis) for the treatment of myopic choroidal neovascularizationGraefes Arch Clin Exp Ophthalmol200924731131819043731
   PubMed Web of Science ®Google Scholar
• LalloumFSouiedEHBastuji-GarinSIntravitreal ranibizumab for choroidal neovascularisation complicating pathologic myopiaRetina20103039940620038864
   PubMed Web of Science ®Google Scholar
• IkunoYSayanagiKSogaKIntravitreal bevacizumab for choroidal neovascularization attributable to pathological myopia: one year resultsAm J Ophthalmol200914794.e1100.e118774550
   PubMed Web of Science ®Google Scholar
• MandalSVenkateshPSampangiRGargSIntravitreal bevacizumab (Avastin) as primary treatment for myopic choroidal neovascularizationEur J Ophthalmol20071762062617671940
   PubMed Web of Science ®Google Scholar
• HayashiKOhno-MatsuiKShimadaNIntravitreal bevacizumab on myopic choroidal neovascularization that was refractory to or had recurred after photodynamic therapyGraefes Arch Clin Exp Ophthalmol200924760961819148667
   PubMed Web of Science ®Google Scholar
• YamamotoIRogersAHReichelEYatesPADukerJSIntravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopiaBr J Ophthalmol20079115716016870653
   PubMed Web of Science ®Google Scholar
• WuPCChenYJIntravitreal injection of bevacizumab for myopic choroidal neovascularization: 1-year follow-upEye2009232042204519151652
   PubMed Web of Science ®Google Scholar
• VoykovBGeliskenFInhoffenWVoelkerMBartz-SchmidtKUZiemssenFBevacizumab for choroidal neovascularization secondary to pathologic myopia: is there a decline of the treatment efficacy after 2 years?Graefes Arch Clin Exp Ophthalmol201024854355020111971
   PubMed Web of Science ®Google Scholar
• ChanWMLaiTYLiuDTLamDSIntravitreal bevacizumab (Avastin) for myopic choroidal neovascularisation: 1-year results of a prospective pilot studyBr J Ophthalmol20099315015418801766
   PubMed Web of Science ®Google Scholar
• ChanWMLaiTYLiuDTLamDSIntravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot studyOphthalmology20071142190219617599414
   PubMed Web of Science ®Google Scholar
• Ruiz-MorenoJMMonteroJAAriasLTwelve-month outcome after one intravitreal injection of bevacizumab to treat myopic choroidal neovascularizationRetina2010301609161520856171
   PubMed Web of Science ®Google Scholar
• Ruiz-MorenoJMMonteroJAIntravitreal bevacizumab to treat myopic choroidal neovascularization: 2-year outcomeGraefes Arch Clin Exp Ophthalmol201024893794120221624
   PubMed Web of Science ®Google Scholar
• Ruiz-MorenoJMMonteroJAGomez-UllaFAresSIntravitreal bevacizumab to treat subfoveal choroidal neovascularisation in highly myopic eyes: 1-year outcomeBr J Ophthalmol20099344845119091851
   PubMed Web of Science ®Google Scholar
• NgDSKwokAKChanCWAnti-vascular endothelial growth factor for myopic choroidal neovascularizationClin Experiment Ophthalmol2012401e98e11021902785
   PubMed Web of Science ®Google Scholar
• HayashiKOhno-MatsuiKTeramukaiSComparison of visual outcome and regression pattern of myopic choroidal neovascularization after intravitreal bevacizumab or after photodynamic therapyAm J Ophthalmol200914839640819427991
   PubMed Web of Science ®Google Scholar
• IkunoYNagaiYMatsudaSTwo-year visual results for older Asian women treated with photodynamic therapy or bevacizumab for myopic choroidal neovascularizationAm J Ophthalmol201014914014619846061
   PubMed Web of Science ®Google Scholar
• BabaTKubota-TaniaiMKitahashiMOkadaKMitamuraYYamamotoSTwo-year comparison of photodynamic therapy and intravitreal bevacizumab for treatment of myopic choroidal neovascularisationBr J Ophthalmol20109486487019965833
   PubMed Web of Science ®Google Scholar
• GharbiyaMAllieviFMazzeoLGabrieliCBIntravitreal bevacizumab treatment for choroidal neovascularization in pathologic myopia: 12-month resultsAm J Ophthalmol20091478493e118774547
   PubMed Web of Science ®Google Scholar
• YoonJUKimYMLeeSJByunYJKohHJPrognostic factors for visual outcome after intravitreal anti-VEGF injection for naïve myopic choroidal neovascularizationRetina201232594995522534553
   PubMed Web of Science ®Google Scholar
• IaconoPParodiMBPapayannisAKontadakisSShethSBandelloFIntravitreal bevacizumab therapy on an as-per-needed basis in subfoveal choroidal neovascularization secondary to pathological myopia: 2-year outcomes of a prospective case seriesRetina2011311841184721775926
   PubMed Web of Science ®Google Scholar
• MilaniPPeceAMorettiGLinoPScialdoneAIntravitreal bevacizumab for CNV-complicated tilted disk syndromeGraefes Arch Clin Exp Ophthalmol20092471179118219412700
   PubMed Web of Science ®Google Scholar
• GharbiyaMGiustolisiRAllieviFChoroidal neovascularization in pathologic myopia: intravitreal ranibizumab versus bevacizumab – a randomized controlled trialAm J Ophthalmol2010149458. e1464. e120172072
   PubMed Web of Science ®Google Scholar